Salus IRB

As an AAHRPP-accredited, unbiased, non-profit IRB, Salus IRB is committed to upholding the highest standards in human research protection while providing the same high level of service and expertise that our customers have relied on for more than 35 years.


Salus IRB employs a consultative partnership approach when working with sponsors and investigators, providing added value by delivering IRB services in a convenient, reliable and efficient manner.

Benefits Include:

Dedicated client service managers
Streamlined document submission and delivery process
Industry-leading review and response times
IRB meetings held every Monday, Tuesday, Wednesday and Friday
Same-day expedited review
Comprehensive review services for phase I-IV research
Experience in toxicology and accelerated phase I review services
Dedicated oncology board with experience reviewing oncology research, including phase I
Single IRB / Central IRB services for multi-site trials

Explore our broad range of specialized services

IRB Review Boards

Expert physicians, pharmacists, attorneys and toxicologists.

Minimal Risk / IRB Exempt Services

Single-site, multi-site and international review services for clinical trials.

Research Review Services

Salus IRB board members include expert physicians, pharmacists, attorneys, toxicologists and more. They review phase I-IV clinical trials, as well as post-marketing research, in a variety of therapeutic areas.

Expert guidance. Every phase. Every day.


Cenetron is an industry-leading central laboratory service provider for the facilitation of unique pharmaceutical clinical trials.


Versiti has more than 75 years of experience in blood health innovation, including research, diagnostic testing and clinical trials.